[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.147.69. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 347
Citations 0
Comment & Response
September 2015

Radiation Oncologist Concerns About Increased Electronic Brachytherapy Use for Skin Cancer—Reply

Author Affiliations
  • 1Department of Dermatology, University of California San Francisco School of Medicine, San Francisco
  • 2Department of Dermatology, University of Iowa, Iowa City
  • 3Department of Epidemiology, University of Iowa, Iowa City
  • 4Philip R. Lee Institute for Health Policy Studies, University of California San Francisco School of Medicine, San Francisco
JAMA Dermatol. 2015;151(9):1037. doi:10.1001/jamadermatol.2015.2007

In Reply We thank our colleagues at the American Society for Therapeutic Radiology and Oncology (ASTRO) for their letter supporting our Viewpoint on the sudden and concerning rise in use of electronic brachytherapy (EBT).1 Both the American Academy of Dermatology (AAD) position statement2 and ASTRO’s letter clearly show that major national specialty societies are putting quality care and patient safety first—and that speaks well of the house of medicine and its professional organizations.

First Page Preview View Large
First page PDF preview
First page PDF preview
×